QualityStocksNewsBreaks Archives - Page 844 of 1423

WednesdayOct 28, 2020 12:22 pm

QualityStocksNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Secures Financing to Fund Phase 2 Clinical Trials and Phase 3 Preparations

AzurRx BioPharma (NASDAQ: AZRX), a clinical-stage biopharmaceutical company, in July entered into a convertible preferred stock and warrant securities purchase agreement with certain accredited and institutional investors relating to the private placement of certain shares of convertible preferred stock and warrants for cash and in exchange for certain outstanding promissory notes as described in a recent update. In addition, the company entered into an exchange addendum to the purchase agreement with certain investors, relating to the exchange, as consideration in the private placement, of approximately $6.9 million aggregate in principal amount, plus all accrued and unpaid interest thereon, of its outstanding…

WednesdayOct 28, 2020 10:57 am

QualityStocksNewsBreaks – ISW Holdings Inc. (ISWH) Announces Breakout Revenues, Aggressive Moves to Remove Dilution Risk, Plans to Uplist

ISW Holdings (OTC: ISWH), a global brand management holdings company, today announced a preliminary qualitative performance update for the three months ended Sept. 30, 2020. In addition, ISWH provided an update on its recent moves to significantly reduce debt and authorized shares, as well as its plans to uplist to the OTCQB exchange tier. While precise data is not yet available in a form that may be publicly announced, ISW Holdings disclosed another breakout quarter, with new record high revenues for the three months ended Sept. 30, 2020. “Our Home Healthcare and Telehealth segment continues to expand significantly, and we…

WednesdayOct 28, 2020 10:44 am

QualityStocksNewsBreaks – SRAX Inc. (NASDAQ: SRAX) to Present at Zooming with LD

SRAX (NASDAQ: SRAX), an innovative fintech solutions provider that unlocks data and insights for publicly traded companies through its SaaS platform, Sequire, today announced that it will present virtually at Zooming with LD. SRAX’s presentation is slated to take place at 11:00 a.m. ET on Friday, Oct. 30, 2020. Chris Miglino, chief executive officer of SRAX, will be giving the presentation and answering questions from investors. Investors and other interested parties may register at https://ibn.fm/6BqfU to access the live, virtual presentation. To view the full press release, visit https://ibn.fm/zcvNt About SRAX Inc. SRAX is a financial technology company that unlocks data…

WednesdayOct 28, 2020 10:22 am

QualityStocksNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Releases Q3 2020 Financials, Marks Record Numbers

Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, has released financial numbers for its third quarter. Financial highlights include third-quarter revenues up by 174% to $6.3 million, compared to revenue of $2.3 million in the same quarter last year; third-quarter gross profit increased 47% to $1.9 million, compared to gross profit of $1.3 million in the same quarter last year; and third-quarter net income reached $0.14 million compared to net income in the same quarter last year. Business highlights for the quarter included the addition of 144 new independent pharmacies; the unveiling of Bonum+, a B2B platform that…

TuesdayOct 27, 2020 2:22 pm

QualityStocksNewsBreaks – Knightscope Inc. Appoints Experienced Financial Exec as CFO, Announces Online Opportunity to Invest

Knightscope, a developer of advanced physical security technologies utilizing fully autonomous robots focused on enhancing U.S. security operations, today announced the appointment of Mallorie Burak as the company’s executive vice president and chief financial officer. Burak brings to the company over 25 years of expertise across a broad spectrum of industries ranging from early stage start-ups to multi-national public corporations. Over the span of her career, she has negotiated and managed over $500 million of successful financing and M&A deals and has focused the last 13 years on turnarounds and special situations for both public and venture-backed companies. In addition,…

TuesdayOct 27, 2020 2:10 pm

QualityStocksNewsBreaks – Sugarmade Inc. (SGMD) Has ‘Strategic Pieces in Place to Capitalize on Cultivation’

Sugarmade (OTCQB: SGMD), a leading, multidivisional/multiproduct/multisector supply company, recently entered into an agreement to lease five acres of land in Northern California (https://ibn.fm/d1XdV). SGMD intends to use the property, which is zoned for cannabis cultivation, to establish and operate licensed production with the capacity to produce as much as 3.6 million grams of high-quality cannabis flower per year. “We believe we have all of the strategic pieces in place to capitalize on cultivation, with the market currently chronically undersupplied,” Sugarmade chairman of the board, CEO and CFO Jimmy Chan said in an update. “We also have relationships in place, especially through…

TuesdayOct 27, 2020 1:55 pm

QualityStocksNewsBreaks – Rritual Mushrooms Inc.’s New Line of Elixirs Provides ‘Daily Dose’ with Powerful Benefits

Rritual, a plant-based consumer wellness brand, is positioning to take advantage of opportunity in the functional food and mushroom market with the fall launch of its innovative suite of premium functional mushroom and adaptogenic elixirs. “The health and wellness benefits of mushrooms and plant-based therapies are backed by decades of scientific research,” Dr. Mike Hart, president of Rritual, who also oversaw the development of the new line of products, stated of the launch (https://ibn.fm/bW2n6). “Rritual’s new line of elixirs embraces that research and provides consumers with an easy way to get a daily dose of the powerful effects.” To view…

TuesdayOct 27, 2020 1:52 pm

QualityStocksNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Announces Positive Results in Ongoing Phase 2 Combination Therapy Trial with MS1819

AzurRx BioPharma (NASDAQ: AZRX), a clinical-stage biopharmaceutical company, recently announced positive results from the first five patients in its Phase 2 combination therapy trial of MS1819 for the treatment of severe exocrine pancreatic insufficiency (“EPI”) in patients with cystic fibrosis (“CF”). In the primary efficacy analysis, patients receiving MS1819 in combination with PERT therapy achieved a clinically meaningful improvement in the coefficient of fat absorption (“CFA”) at each of the three dose levels. No adverse safety events were reported and, additionally, patients showed improvements in the key secondary endpoints, including body weight, stool consistency and reductions in the number of bowel…

TuesdayOct 27, 2020 1:10 pm

QualityStocksNewsBreaks – Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) Featured on Critical Minerals Segment of ‘Mornings with Maria’

Standard Lithium (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF), an innovative technology and lithium project development company, today announced that its CEO Robert Mintak was a featured guest on Fox Business Network’s “Mornings with Maria” with anchor Maria Bartiromo. During the segment, which aired on Monday October 26, 2020, the two discussed the need for the lithium industry to adjust the critical minerals supply chain from China to the United States. Mintak summarized the progress being made at Standard Lithium’s Arkansas project. He highlighted the fact that currently the only lithium extraction that is actively underway in the U.S. is at…

TuesdayOct 27, 2020 12:31 pm

QualityStocksNewsBreaks – Predictive Oncology (NASDAQ: POAI) CEO Provides Company Updates on Exclusive NNW Audio Interview

Predictive Oncology (NASDAQ: POAI) CEO Carl Schwartz was featured in a recent NetworkNewsWire (“NNW”) audio interview. During the interview, Schwartz provided updates on the company’s subsidiaries, noted recent company milestones and outlined near-term goals. POAI, a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, has four wholly owned subsidiaries: Helomics, TumorGenesis, Skyline Medical and Soluble Biotech. Schwartz focused the discussion on these companies, offering brief insight into the operations of Skyline Medical and noting that the purpose of TumorGenesis was to develop a lab media to replace rats and mice in the scientific industries…

Site Search

Company Search

Category: QualityStocksNewsBreaks